Post‐translational modification by O‐GlcNAc: Another way to change protein function
暂无分享,去创建一个
[1] G. Hart,et al. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. , 1994, The Journal of biological chemistry.
[2] E. Meese,et al. Novel immunogenic antigen homologous to hyaluronidase in meningioma. , 1998, Human molecular genetics.
[3] N. Olszewski,et al. SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn. , 2006, Journal of experimental botany.
[4] J. E. Kudlow,et al. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. , 2001, The Biochemical journal.
[5] Xiaoyong Yang,et al. An N-terminal Region of Sp1 Targets Its Proteasome-dependent Degradation in Vitro* , 1999, The Journal of Biological Chemistry.
[6] G. Hart,et al. Glycosylation of the murine estrogen receptor-alpha. , 2000, The Journal of steroid biochemistry and molecular biology.
[7] R. Tjian,et al. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.
[8] J. E. Kudlow,et al. Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets. , 2000, Biochemical and biophysical research communications.
[9] R. Kornfeld. Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. , 1967, The Journal of biological chemistry.
[10] G. Hart,et al. O-GlcNAc: a regulatory post-translational modification. , 2003, Biochemical and biophysical research communications.
[11] G. Hart,et al. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. , 2001, Analytical biochemistry.
[12] G. Hart,et al. Perturbations in O-linked β-N-Acetylglucosamine Protein Modification Cause Severe Defects in Mitotic Progression and Cytokinesis* , 2005, Journal of Biological Chemistry.
[13] A. Paterson,et al. Location and characterization of the O-GlcNAcase active site. , 2006, Biochimica et biophysica acta.
[14] G. Hart,et al. Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress , 2004, Journal of Biological Chemistry.
[15] A. Paterson,et al. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. , 2000, The Biochemical journal.
[16] Eric C. Griffith,et al. The Many Forks in FOXO's Road , 2003, Science's STKE.
[17] G. Hart,et al. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. , 1997, Annual review of biochemistry.
[18] E. Meese,et al. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. , 2001, Biochemical and biophysical research communications.
[19] G. Hart,et al. O-Glycosylation of Nuclear and Cytosolic Proteins , 2000, The Journal of Biological Chemistry.
[20] O. Sezer,et al. Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion , 2003, Journal of Cancer Research and Clinical Oncology.
[21] J. Wyss,et al. Accumulation of protein O‐GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O‐GlcNAc metabolism , 2004, Journal of neurochemistry.
[22] Xiaoyong Yang,et al. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Paterson,et al. Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases , 1990, Molecular and cellular biology.
[24] G. Hart,et al. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. , 2001, Biochemistry.
[25] A. Paterson,et al. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] K. Kim. Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death. , 2001, Biochemical and biophysical research communications.
[27] A. Paterson,et al. Characterization of the Histone Acetyltransferase (HAT) Domain of a Bifunctional Protein with Activable O-GlcNAcase and HAT Activities*♦ , 2004, Journal of Biological Chemistry.
[28] G. Hart,et al. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. , 2002, Current opinion in chemical biology.
[29] Xiaoyong Yang,et al. O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome , 2003, Cell.
[30] S. Milligan,et al. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. , 2001, Anticancer research.
[31] T. Shin,et al. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression , 1992, Molecular and cellular biology.
[32] J. Kuromitsu,et al. cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. , 1999, Genomics.
[33] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.
[34] G. Hart,et al. Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.
[35] D. Coppola,et al. CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice. , 2001, Cancer research.
[36] M. Hengartner. Apoptosis Corralling the Corpses , 2001, Cell.
[37] R. Haltiwanger,et al. Mitotic Arrest with Nocodazole Induces Selective Changes in the Level of O-Linked N-Acetylglucosamine and Accumulation of Incompletely Processed N-Glycans on Proteins from HT29 Cells* , 1997, The Journal of Biological Chemistry.
[38] F. Chen,et al. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[39] S. Safe,et al. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. , 2003, Endocrinology.
[40] P. O'Hara,et al. Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase. , 1992, The Journal of biological chemistry.
[41] J. E. Kudlow,et al. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions , 1997, Molecular and cellular biology.
[42] D. Barford,et al. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR‐mediated protein–protein interactions , 1998, The EMBO journal.
[43] I. Han,et al. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.
[44] G. Hart,et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[45] N. Greenspan,et al. Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Paterson,et al. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death , 2000 .
[47] L. Freedman. Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.
[48] A. Paterson,et al. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[49] N. Barzilai,et al. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.
[50] J. Hanover,et al. O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.
[51] Gerald W. Hart,et al. Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.
[52] J. E. Kudlow,et al. Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. , 2001, Biochemical and biophysical research communications.
[53] A. Paterson,et al. Role of glucosamine synthesis in the stimulation of TGF-alpha gene transcription by glucose and EGF. , 1996, The American journal of physiology.
[54] D. Wang,et al. Cloning and partial characterization of the mouse glutamine:fructose-6-phosphate amidotransferase (GFAT) gene promoter. , 1997, Nucleic acids research.
[55] Xiaoyong Yang,et al. Phosphorylation of Human Glutamine:Fructose-6-phosphate Amidotransferase by cAMP-dependent Protein Kinase at Serine 205 Blocks the Enzyme Activity* , 2000, The Journal of Biological Chemistry.
[56] R. Duggirala,et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. , 2005, Diabetes.
[57] R. Tjian,et al. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.
[58] G. Hart,et al. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[59] W. G. Kelly,et al. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. , 1993, The Journal of biological chemistry.
[60] A. Paterson,et al. Regulation of glutamine:fructose-6-phosphate amidotransferase gene transcription by epidermal growth factor and glucose. , 1995, Endocrinology.
[61] R. Tjian,et al. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] I. G. Fantus,et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[63] G. Hart,et al. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. , 2005, Endocrinology.
[64] J. Hanover,et al. Mutational Analysis of the Catalytic Domain of O-Linked N-Acetylglucosaminyl Transferase* , 2005, Journal of Biological Chemistry.
[65] Q. Dou,et al. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] V. Hascall,et al. Proteoglycan core protein families. , 1986, Annual review of biochemistry.
[67] G. Hart,et al. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[68] U. Sauer,et al. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. , 1998, The Journal of clinical investigation.
[69] B. V. Van Tine,et al. Assignment of N-acetyl-D-glucosaminidase (Mgea5) to rat chromosome 1q5 by tyramide fluorescence in situ hybridization (T-FISH): synteny between rat, mouse and human with Insulin Degradation Enzyme (IDE) , 2004, Cytogenetic and Genome Research.
[70] C. Glass,et al. The histone deacetylase-3 complex contains nuclear receptor corepressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Jinek,et al. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.
[72] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[73] G. Hart,et al. c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.
[74] A. Paterson,et al. The Histone Acetyltransferase NCOAT Contains a Zinc Finger-like Motif Involved in Substrate Recognition* , 2006, Journal of Biological Chemistry.
[75] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.
[76] L. Gerace,et al. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins , 1987, The Journal of cell biology.
[77] Y Li,et al. [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[78] J. E. Kudlow,et al. Glucose Metabolism to Glucosamine Is Necessary for Glucose Stimulation of Transforming Growth Factor-α Gene Transcription* , 1996, The Journal of Biological Chemistry.
[79] C. Newgard,et al. STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing Cells , 1994, Diabetes.
[80] P. Elliott,et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. , 2001, Cancer research.
[81] C. Glass,et al. Eya protein phosphatase activity regulates Six1–Dach–Eya transcriptional effects in mammalian organogenesis , 2003, Nature.
[82] G. Parker,et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[83] K L Williams,et al. An in vivo approach for the identification of acceptor sites for O-glycosyltransferases: motifs for the addition of O-GlcNAc in Dictyostelium discoideum. , 1997, Biochemistry.
[84] R. Tjian,et al. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.
[85] G. Hart,et al. O-GlcNAc and the control of gene expression. , 1999, Biochimica et biophysica acta.
[86] R. Tjian,et al. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. , 1991, Genes & development.
[87] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[88] James O. Wrabl,et al. Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. , 2001, Journal of molecular biology.
[89] M. Hengartner,et al. Death and more: DNA damage response pathways in the nematode C. elegans , 2004, Cell Death and Differentiation.
[90] G. Hart,et al. O‐GlcNAc turns twenty: functional implications for post‐translational modification of nuclear and cytosolic proteins with a sugar , 2003, FEBS letters.
[91] A. Paterson,et al. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog. , 2006, Biochemical and biophysical research communications.
[92] A. Paterson,et al. Phosphorylation of Mouse Glutamine-Fructose-6-phosphate Amidotransferase 2 (GFAT2) by cAMP-dependent Protein Kinase Increases the Enzyme Activity* , 2004, Journal of Biological Chemistry.
[93] A. Paterson,et al. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion , 2002, Molecular and Cellular Endocrinology.
[94] Marcel Garcia,et al. Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis , 1996, Stem cells.
[95] M. Robertson,et al. Identification of a Negative Regulator of Gibberellin Action, HvSPY, in Barley , 1998, Plant Cell.
[96] Xiaoyong Yang,et al. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. , 1998, Proceedings of the Association of American Physicians.
[97] V. Rotter,et al. Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability To Stabilize p53 , 2001, Molecular and Cellular Biology.
[98] M G McInnis,et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.
[99] W. G. Kelly,et al. Localization of O-GlcNAc modification on the serum response transcription factor. , 1992, The Journal of biological chemistry.
[100] C. Glass,et al. A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.
[101] G. Hart,et al. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. , 2001, The Journal of biological chemistry.
[102] Xiaoyong Yang,et al. Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A Coupling Protein O-GlcNAcylation to Transcriptional Repression , 2002, Cell.
[103] N. J. Patton,et al. Mechanisms of nitrosourea-induced beta-cell damage. Alterations in DNA. , 1986, Diabetes.
[104] N. J. Patton,et al. Mechanisms of Nitrosourea-Induced β-Cell Damage: Alterations in DNA , 1986, Diabetes.
[105] J. Hanover,et al. Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro. , 1990, The Journal of biological chemistry.
[106] G. Hart,et al. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.
[107] M. Mcdaniel,et al. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. , 1993, Biochemical and biophysical research communications.
[108] G. Hart,et al. Glycosylation of the murine estrogen receptor-α , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[109] G. Hart,et al. Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability , 2004, Molecular and Cellular Biology.
[110] S. Snyder,et al. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Direnzo,et al. p300 is a component of an estrogen receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[112] Xiaoyong Yang,et al. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. , 2006, Glycobiology.
[113] P. Shaw,et al. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. , 1996, Oncogene.